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Abstract 
The replacement of the calcified cartilage by
bone tissue during the endochondral ossifica-
tion of the mandibular condyle is dependent of
the resorbing activity of osteoclats. After par-
tial resorption, calcified cartilage septa are
covered by a primary bone matrix secreted by
osteoblasts. Osteoadherin (OSAD) is a small
proteoglycan present in bone matrix but
absent in cartilage during the endochondral
ossification. The aim of this study was to ana-
lyze the effect of alendronate, a drug known to
inhibit bone resorption by osteoclasts, on the
endochondral ossification of the mandibular
condyle of young rats, by evaluating the distri-
bution of osteoclasts and the presence of
OSAD in the bone matrix deposited. Wistar
newborn rats (n=45) received daily injections
of alendronate (n=27) or sterile saline solu-
tion as control (n=18) from the day of birth
until the ages of 4, 14 and 30 days. At the days
mentioned, the mandibular condyles were col-
lected and processed for transmission electron
microscopy analysis. Specimens were also sub-
mitted to tartrate resistant acid phosphatase
(TRAP) histochemistry and ultrastructural
immunodetection of OSAD. Alendronate treat-
ment did not impede the recruitment and
fusion of osteoclasts at the ossification zone
during condyle growth, but they presented
inactivated phenotype. The trabeculae at the
ossification area consisted of cartilage matrix
covered by a layer of primary bone matrix that
was immunopositive to OSAD at all time points
studied. Apparently, alendronate impeded the
removal of calcified cartilage and maturation
of bone trabeculae in the mandibular ramus,
while in controls they occurred normally.
These findings highlight for giving attention to
the potential side-effects of bisphosphonates
administered to young patients once it may
represent a risk of disturbing maxillofacial
development.
Introduction
The mandibular condyle that develops by
endochondral ossification is a growth site of
the mandible. The temporomandibular joint is
the only synovial joint in the body in which its
bone surfaces are covered by a layer of dense
connective tissue rather than by a hyaline
(articular) cartilage,1 the same connective tis-
sue that constitutes the temporomandibular
articular disc.2 Early in embryonic develop-
ment, however, endochondral ossification
starts into a hyaline cartilage that arises from
a condylar blastema. Therefore, as in other
parts of the body where that process takes
place, chondrocytes proliferate, become hyper-
trophied and then undergo apoptosis, provid-
ing a condition in which the cartilaginous
matrix mineralizes.3 Clastic cells resorb some
areas of calcified matrix for allowing capillar-
ies and undifferentiated cells to invade the
cavities previously filled by chondrocytes.4,5
The primary bone secreted over the calcified
cartilage septa contains abundant collagen fib-
rils arranged in a disorganized network with
interspersed noncollagenous proteins and pro-
teoglycans. Differently from other small
leucine-rich proteoglycans (SLRPs) present in
the other connective tissues of the temporo-
mandibular joint,6,7 osteoadherin (OSAD) is
present in the extracellular matrix of bone and
other mineralized tissues.8 In bone matrix,
OSAD is localized into cement lines and min-
eralizing fronts, being absent into the mineral-
ized cartilage that remain at the center of the
bone trabeculae.9 Indeed, OSAD has been
detected during endochondral ossification of
rat femora,10 but its precise distribution has
not been well established. The first layers of
primary bone deposited over calcified cartilage
are subsequently remodeled into mature bone.
Thus, the association between resorptive
activity by clastic cells and bone matrix forma-
tion by osteoblasts is crucial for the mandibu-
lar condyle growth.
Bisphosphonates are a class of drugs that
inhibit osteoclast-mediated bone resorption,
and are widely used in prevention and treat-
ment of bone diseases such as osteoporosis,
Paget’s disease and metastatic bone cancer.11
Nitrogen-containing bisphosphonates cause
disorders in clastic cell cytoskeleton and intra-
cellular signaling, inhibit adhesion mecha-
nisms and yield structural changes in the ruf-
fle border, as well as decrease of their acid pro-
duction. As a result, osteoclasts may become
latent or inactive and subsequently undergo
apoptosis12,13 or only lose their resorptive abili-
ty,14 yielding to reduced bone remodeling15,16
and osteogenic potential.17
Sodium alendronate is widely employed in
therapy of several pediatric and juvenile bone
disorders,18-20 and its administration can possi-
bly induce alterations during skeletal growth of
children. Several experiments have been car-
ried out in the last decades in order to investi-
gate the effects of bisphosphonates on skeletal
and dental development. The administration of
alendronate to young growing rats undergoing
tooth development alters both enamel and
dentin matrix;21 pamidronate treatment delays
the eruption of rat teeth,22 while alendronate
completely impairs the eruption of molars in
rats.23 Alendronate reduces bone resorption
and inhibits long bone growth in an osteogen-
esis imperfecta mouse model.24 Previous stud-
ies have reported the enlargement of the carti-
lage zone as effect of bisphosphonate treat-
ment.25-29
The aim of this study was to investigate the
effect of sodium alendronate on the endochon-
dral ossification of the mandibular condyle of
young rats. In order to test the hypothesis that
this drug may affect the clastic activity during
the endochondral ossification in the mandibu-
lar condyle, we treated newborn rats with sodi-
um alendronate up to 30 days. Then, ultra-
structural techniques were applied in order to
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examine whether clastic cells are present and
their morphology, as well as the structure of
the primary bone trabeculae. As OSAD is pres-
ent at the primary bone but not into the calci-
fied cartilage septa, high resolution immuno-
cytochemical labeling was made for clearly dis-
tinguishing primary bone from cartilage.
Materials and MethodsAnimals
Principles of laboratory animal care (NIH
publication 85-23, 1985) and national laws on
animal use were observed for the present
study, which was authorized by the Ethical
Committee for Animal Research of the
University of São Paulo, Brazil. Forty-five new-
born Wistar albino rats were used in this study.
Twenty seven rats were subjected to daily sub-
cutaneous injections of 2.5 mg/kg of sodium
alendronate21,23 since the day of birth to 4, 14
and 30 days old. Additional eighteen rats were
daily injected with saline during the same peri-
ods. All the alendronate-treated rats were not
weaned during the entire study in order to
have their nutrition provided maternally.Tissue preparations
At the time points cited, nine alendronate-
treated and six control rats were anesthetized
with 1 mL/kg body weight of 2% chloridrate 2-
(6,6-xilidine)-5,6-dihydro-4-H-1,3-tiazine
diluted 1:1 in ketamine, decapitated and had
their mandibular condyles dissected out and
immediately fixed in 2% glutaraldehyde and
2.5% formaldehyde buffered in 0.1 M sodium
cacodylate, pH 7.4. Specimens were immersed
in fixative solution at room temperature,
which was placed in a Pelco 3440 laboratory
microwave oven (Ted Pella, Redding, CA, USA)
and then exposed to microwave irradiation at
100% setting for 3 cycles of 5 min, with the
temperature programmed to a maximum of
37°C. After microwave irradiation, specimens
were transferred into fresh fixative solution
and left submersed in that overnight at 4°C.30
They were rinsed in 0.05 M cacodylate buffer
and decalcified in 4.13% ethylenediaminete-
traacetic acid (EDTA) for 20 days. Then, speci-
mens were processed for embedding in differ-
ent materials.Light microscopy
The condylar processes from three alen-
dronate-treated and two control rats from each
group were dehydrated in graded ethanol con-
centrations and embedded in JB-4 historesin
(Polysciences, Warrington, PA, USA). Three-
μm thick sections were collected onto glass
slides stained in hematoxylin and acid fuchsin
for morphological analysis, and additional sec-
tions were submitted to tartrate resistant acid
phosphatase (TRAP) histochemistry. The sec-
tions were incubated in Burstone’s complete
medium (Sigma Chemical Co., St. Louis, MO,
USA), which was prepared by dissolving 4 mg
naphtol As-Bi phosphate substrate in 0.25 mL
of N-N-dimethylformamide, followed by addi-
tion of 25 mL of 0.2 M acetate buffer pH 5.0, 35
mg of Fast Red Violet LB as the coupling agent
and 60 μL of 10% MgCl. Next, 25 mL of the
medium was filtered into a Coplin jar and
warmed to 37°C, followed by the addition of 50
mM D(-) tartaric acid. The slides containing
the sections were incubated during 2 h. After
that, the slides were washed in tap water and
counterstained with Harris' hematoxylin for 10
min.31 Coverslips were mounted with Entellan
(Merck, Germany) and the slides were exam-
ined and photographed in an Olympus BX-60
light microscope.Transmission electron microscopy
The condylar processes from other three
alendronate-treated and two control rats from
each time point were post-fixed in 0.1 M
cacodylate-buffered 1% osmium tetroxide for 2
h at room temperature, dehydrated in graded
concentrations of alcohol, and embedded in
Spurr resin (Electron Microscopy Sciences, PA,
USA) for ultrastructural analyzes. Toluidine
blue-stained 1 μm thick sections were exam-
ined and endochondral ossification regions of
the condyle were selected for ultrathin section-
ing. Sections 80-nm thick were obtained with a
diamond knife on a Leica Ultracut R ultrami-
crotome (Leica, Buffalo, NY, USA), collected
onto 200-mesh copper grids, stained with
uranyl acetate and lead citrate, and examined
in a Jeol 1010 transmission electron micro-
scope operated at 80 kV.Post embedding colloidal-goldimmunocytochemistry for osteoadherin
The condylar processes from three alen-
dronate-treated and two control rats from each
group destined to immunocytochemical anal-
izes were fixed under microwave irradiation as
described previously. However, the fixative
solution used for this group contained 0.1%
glutaraldehyde and 4% formaldehyde buffered
in 0.1 M cacodylate, pH 7.4. The specimens
were decalcified as described, dehydrated and
embedded in LR White resin (London Resin
Company, UK). Nickel grid-mounted 80 nm-
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Figure 1. Light micrographs of hematoxylin and acid fuchsin-stained sections. At 30 days,
condyles of control specimens in (a), present calcified cartilage (arrows) at the ossification
area; the bone trabeculae (bm) present remodeled appearance; scale bar: 80 µm. The inset
illustrates the distal ossification portion at higher magnification, where few calcified car-
tilage areas surrounded by bone matrix are seen; scale bar: 20 µm. The alendronate-treat-
ed specimens in (b) present cartilage (arrows) at the ossification and in the interior of the
trabeculae; scale bar: 80 µm. The inset shows numerous calcified cartilage septa with
small amount of bone matrix secreted over them. CC, calcified cartilage. Scale bar: 20 µm.
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thick tissue sections were incubated 20 min on
a drop of 0.01M phosphate-buffered saline
(PBS) solution containing nonfat milk, and
then transferred to a drop of rabbit anti-rat
osteoadherin8 for incubation for 24 h at room
temperature, followed by incubation for 30 min
at room temperature with protein A-gold com-
plex. Negative controls for specificity of label-
ing consisted of incubating the sections with
protein A-gold alone. The tissue sections were
rinsed thoroughly with PBS followed by dis-
tilled water, and air-dried. The staining was
made with uranyl acetate and lead citrate and
sections were viewed in a Jeol 1010 transmis-
sion electron microscope operated at 80 kV.
Results
The regions analyzed were the calcified car-
tilage and ossification zones at the developing
mandible of rats treated with sodium alen-
dronate or saline solution since their day of
birth until 4, 14 and 30 days.Light microscopy
The hematoxylin and acid fuchsin-stained
sections of control rats at all the time points
revealed the calcified cartilage matrix at prox-
imal areas of the condyle that is resorbed at
the distal region in which only spongy bone is
observed (Figure 1a). In the alendronate-treat-
ed specimens there is a prevalence of cartilage
matrix inside the trabeculae of the mandibular
ramus at distal areas (Figure 1b).Tartrate resistant acid phosphatasehistochemistry
At day 4, the control group presented numer-
ous TRAP-positive clastic cells at the calcified
cartilage and ossification zones (Figure 2a).
They were multinucleated and attached to the
calcified cartilage septa (Figure 2b). At the
same time point, the alendronate-treated spec-
imens presented as many TRAP-positive clas-
tic cells at the same regions as the controls
(Figure 2c); however, these cells did not
appear to be attached to the mineralized sur-
faces. Otherwise, they were rounded and loose
in the marrow spaces (Figure 2d). The speci-
mens at day 14 presented numerous TRAP-pos-
itive cells at the same areas as day 4 did
(Figure 2e), and most of them were resorbing
the calcified cartilage (Figure 2f).
Alendronate-treated condyles were also plenty
of TRAP-positive cells (Figure 2g), but they
still presented the same phenotype as alen-
dronate-treated specimens at day 4 (Figure
2h). The endochondral ossification process
persisted until day 30, when the calcified carti-
lage and ossification zone still exhibited mult-
inucleated and TRAP-positive cells (Figure 2i).
The mandibular ramus of these animals pre-
sented thick remodeled bone trabeculae, and
few osteoclasts were observed over them
(Figure 2j). The specimens treated with alen-
dronate also presented numerous TRAP-posi-
tive cells at calcified cartilage and ossification
areas at day 30 (Figure 2k). However, unlike
controls, their mandibular ramus presented
thin trabeculae constituted of calcified carti-
lage covered by thin layer of bone matrix with
non-remodeled appearance. It were observed
some TRAP-positive clastic cells at medular
spaces, still presenting the same latent pheno-
type observed in the treated specimens at 4
and 14 days.Transmission electron microscopy
Ultrastructural analyzes showed, at the ossi-
fication zone of endochondral ossification,
bone matrix deposited by osteoblasts over the
calcified cartilage septa (Figure 3a).
Multinucleated active clastic cells were
adhered to the mineralized surfaces through
their sealing zones, and presented exuberant
ruffled border, clear zone and numerous vac-
uoles at the cytoplasm (Figure 3b). The alen-
dronate-treated rats also presented calcified
cartilage septa with bone matrix deposited by
osteoblasts over them at the zone of ossifica-
tion (Figure 3 c,d,e). The alendronate-treated
clastic cells, when analyzed at the ultrastruc-
tural level, did not present the same phenotype
of controls. Otherwise, they were not polarized,
rounded-shaped and did not present adhesion
structures and resorbing organelles such as
clear zone and ruffled border (Figure 3f).Ultrastructural localization ofosteoadherin
Ultrathin sections of the mandibular ramus
of 30 day old alendronate-treated specimens
presented immunolabeling to OSAD at the
bone matrix layer that covered the cartilage
tags. The gold particles were localized adjacent
to collagen fibrils (Figure 4a), in the interfib-
rillar spaces of the matrix (Figure 4b) and at
appositional cement lines (Figure 4c). No gold
particles were observed at the calcified carti-
lage matrix (Figure 4 a,b). Examining at the
same region in control specimens, gold parti-
cles were found disperse in bone matrix (not
shown).
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Figure 2. Light micrographs illustrating the endochondral ossification area of rat
mandibles histochemically stained for tartrate resistant acid phosphatase (TRAP). At 4
days, control condyles (a, b) presented hypertrophic cartilage (hc) and calcified cartilage
(cc). Numerous TRAP-positive clastic cells (arrows) were resorbing the calcified cartilage
septa at this moment. At the same time point, alendronate-treated specimens (c, d) pre-
sented TRAP-positive clastic cells (arrowheads) as well, but most cells appeared disperse
in the spaces between calcified cartilage sept with no apparent resorbing activity. At 14
days the endochondral ossification persists in controls (e, f ), and numerous resorbing
clastic cells are observed degrading the calcified cartilage matrix. In the alendronate group
(g, h), the clastic cells did not show any signs of resorptive activity, remaining at the same
phenotype observed at 4 days. At 30 days, the calcified cartilage is still being degraded at
proximal areas in the condyle of controls (i, j). At distal regions, the trabecular bone (tb)
is already formed and some clastic cells are still remodelling the bone matrix. However, at
the alendronate group (k, l), the clastic cells still presented the same phenotype observed
at previous time points at proximal regions. At distal regions, the specimens presented tra-
beculae consisted of non-resorbed calcified cartilage where osteoblasts deposited bone
matrix. There were non-resorbing clastic cells around the trabeculae. a, c, e, g, i, j, k, l,
scale bars: 200 µm; b, d, f, h, scale bars: 20 µm.
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Discussion
Calcified cartilage fragments remained
buried inside the formed bone trabeculae at the
mandibular ramus of young rats due to the
inactivation of resorptive activity of clastic cells
by alendronate. The formed trabeculae were
not substituted by lamellar bone during the
endochondral ossification of the mandibular
condyle when alendronate was administrated.
The alendronate-treated specimens showed
numerous TRAP-positive multinucleated cells
in the endochondral ossification taking place
in the mandibular condyle. However, these
cells exhibited latent phenotype because they
were not adhered to the mineralized surfaces
and therefore they did not present ultrastruc-
tural features of a resorbing cell, like sealing
zone and ruffled border.23,32 Thus, the cartilage
septa were covered by bone matrix and
remained unremodeled as mandibular growth
took place in the alendronate-treated rats.
Contrarily, controls presented trabeculae of
bone matrix at the mandibular ramus because
both clastic cells were active: chondroclasts
resorbed the calcified cartilage, and osteo-
clasts resorbed the primary bone trabeculae
containing calcified cartilage septa. In addi-
tion, the presence of numerous latent osteo-
clasts suggests that alendronate treatment did
not impede the recruitment of clastic cell pre-
cursors as well as their fusion, even in the
high dose that was daily administered in our
study, confirming previous studies in the alve-
olar process of jaw bones.23
During endochondral ossification, chondro-
cyte proliferation needs to be synchronized
with clastic cell activity (resorption of calcified
cartilage septa by chondroclasts and that of pri-
mary spongiosa by osteoclasts) for allowing
mandible growth. Thus, alterations in chon-
drocyte proliferation or in chondrocyte hyper-
trophy after alendronate treatment were not
expected findings. Moreover, the calcified car-
tilage septa serve as support for deposition of
bone matrix in order to maintain the longitudi-
nal growth of the region. The numerous inacti-
vated clastic cells failed to resorb the cartilage
septa. It resulted in the elongation of the carti-
lage layer in the mandibular ramus that may
be related to the remaining calcified cartilage
septa into the primary spongiosa rather than to
the lack of hyperthophic cartilage removal by
inactivated chondroclasts, as previously stat-
ed.28,29 Although bisphosphonates are believed
to impair mineralization,11,17 our findings
revealed no alterations in cartilage matrix
mineralization in mandibular condyles from
alendronate-treated rats. The areas of calcified
cartilage matrix were devoid of the small pro-
teoglycan OSAD, which was only present into
the bone matrix. The ultrastructural immuno-
labeling for OSAD showed a normal distribu-
tion of gold particles in the primary bone
matrix around the cartilage septa, similar to
controls, where immunolabeling was diffuse
and disperse over the mature bone matrix, as
previously reported.9
The current data on experiments that
approached the condylar growth under bispho-
sphonate effects indicate that the clastic cells
are inactivated during this process; however,
none of them clarified their cellular structure
with details. Our findings may contribute to
the understanding of the cellular events that
comprise the disturbances occasioned by alen-
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Figure 4. High resolution immunocytochemistry for osteoadherin (OSAD). Transmission
electron micrographs illustrating colloidal-gold immunocytochemical detection of OSAD
at bone trabeculae of mandibles of thirty day-old alendronate-treated rats. Colloidal gold
particles (arrows) indicate the presence of OSAD in interfibrillar spaces of the primary
bone matrix (BM) in (a) and (b.) The mineralized cartilage matrix (C) does not present
labeling. In (c), the gold particles are detected in the cement line (CL) between the bone
matrix and the osteoid (O). Ob, osteoblast. Scale bars: 400 nm.
Figure 3. Transmission electron micrographs illustrating ultrastructural details of the
ossification area of rat mandibles. At four days (a), osteoblasts (Ob) were secreting bone
matrix (BM) over the calcified cartilage tags (CM) in controls. This osteoblast activity was
also observed at the alendronate group (c, d, e). At thirty days, controls presented active
clastic cells resorbing the previously secreted bone matrix at trabecular bone of distal
regions of the mandibular ramus (b). The alendronate group presented cartilage matrix
in the core of trabeculae at the same regions described in the control group (f ). The clas-
tic cells observed were not attached to the bone/cartilage surfaces at their most; however,
sparse shallow resorption lacunae were present over these structures (arrows). LOC, latent
osteoclast. Scale bars: 1.5 µm.
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dronate during endochondral ossification. The
alendronate treatment of young rats signifi-
cantly altered the endochondral ossification of
the mandibular condyle. It did not impede the
recruitment and fusion of precursors of the
clastic cells,23 which were abundant at the ossi-
fication areas, but they remained latent and
could not remodel the calcified cartilage/pri-
mary bone trabeculae into spongy bone at the
mandibular ramus.
As bisphosphonate therapies are recom-
mended for treatment of bone disorders during
childhood such as osteogenesis imperfecta,
juvenile Paget’s disease and secondary osteo-
porosis related to anorexia nervosa, cerebral
palsy and post-renal transplants,18-20 the pres-
ent results highlight the risk of disturbing
maxillofacial growth in young patients that
take bisphosphonate therapy.
References
1. Ten Cate AR. Temporomandibular joint. In:
Ten cate’s oral histology - Development,
structure and function. St. Louis, USA,
Mosby, 2003, pp. 376-96.
2. de Moraes LOC, Lodi FR, Gomes TS,
Marques SR, Oshima CTF, Lancellotti CLP,
et al. Immunohistochemical expression of
types I and III collagen antibodies in the
temporomandibular joint disc of human
foetuses. Eur J Histochem 2011;55:e24.
3. Marchi F, Luder HU, Leblond CP. Changes
in cells secretory organelles and extracel-
lular matrix during endochondral ossifica-
tion in the mandibular condyle of the
growing rat. Am J Anat 1991;190:41-73.
4. Arana-Chavez VE, Bradaschia-Correa V.
Clastic cells: Mineralized tissue resorption
in health and disease. Int J Biochem Cell
Biol 2009;41:446-50.
5. Loreto C, Almeida LE, Migliore MR,
Caltabiano M, Leonardi R. TRAIL, DR5 and
caspase 3-dependent apoptosis in vessels
of diseased human temporomandibular
joint disc. An immunohistochemical study.
Eur J Histochem 2010;54:e40.
6. Kiga N, Tojyo I, Matsumoto T, Hiraishi Y,
Shinohara Y, Fujita S. Expression of lumi-
can related to CD34 and VEGF in the artic-
ular disc of the human temporomandibu-
lar joint. Eur J Histochem 2010;54:e34.
7. Kiga N, Tojyo I, Matsumoto T, Hiraishi Y,
Shinohara Y, Makino S, et al. Expression
of lumican and fibromodulin following
interleukin-1 beta stimulation of disc cells
of the human temporomandibular joint.
Eur J Histochem 2011;55:e11.
8. Couble M-L, Bleicher F, Farges J-C, Peyrol
S, Lucchini M, Magloire H, et al.
Immunodetection of osteoadherin in
murine tooth extracellular matrices.
Histochem Cell Biol 2004;121:47–53.
9. Ramstad VE, Franze´n A, Heinegard D,
Wendel M, Reinholt FP. Ultrastructural dis-
tribution of osteoadherin in rat bone
shows a pattern similar to that of bone
sialoprotein. Calcif Tissue Int 2003;72:57-
64.
10. Shen Z, Gantcheva S, Sommarin Y,
Heinegard D. Tissue distribution of a
novel cell binding protein, osteoadherin,
in the rat. Matrix Biol 1999;18:533-42.
11. Russell RG, Watts NB, Ebetino FH, Rogers
MJ. Mechanisms of action of bisphospho-
nates: similarities and differences and
their potential influence on clinical effica-
cy. Osteoporos Int 2008;19:733-59.
12. Rogers MJ, Gordon S, Benford HL, Coxon
FP, Luckman SP, Monkkonen J, et al.
Cellular and molecular mechanisms of
action of bisphosphonates. Cancer
2000;88:2961-78.
13. Vasikaran SD. Bisphosphonates: an
overview with special reference to alen-
dronate. Ann Clin Biochem 2001;38:608-
23.
14. Halasy-Nagy JM, Rodan GA, Reszka AA.
Inhibition of bone resorption by alen-
dronate and risedronate does not require
osteoclast apoptosis. Bone 2001;29:553-9.
15. Helm NB, Padala S, Beck FM, D’Atri AM,
Huja SS. Short-term zoledronic acid
reduces trabecular bone remodeling in
dogs. Eur J Oral Sci 2010;118:460-5.
16. Wu X, Pang L, Lei W, Lu W, Li J, Li Z, et al.
Inhibition of Sca-1-positive skeletal stem
cell recruitment by alendronate blunts the
anabolic effects of parathyroid hormone
on bone remodeling. Cell Stem Cell 2010;7:
571-80.
17. Bodde EW, Kowalski RS, Spauwen PH,
Jansen JA. No increased bone formation
around alendronate or omeprazole loaded
bone cements in a femoral defect. Tissue
Eng Part A 2008;14:29-39.
18. Maasalu K, Haviko T, Martson A.
Treatment of children with osteogenesis
imperfecta in Estonia. Acta Paediatr
2003;92:452-5.
19. Kamoun-Goldrat A, Ginisty D, Le Merrer M.
Effects of bisphosphonates on tooth erup-
tion in children with osteogenesis imper-
fecta. Eur J Oral Sci 2008;116:195-8.
20. Bachrach LK, Ward LM. Clinical review:
bisphosphonate use in childhood osteo-
porosis. J Clin Endocrinol Metab 2009;
94:400-9.
21. Massa LF, Bradaschia-Correa V, Arana-
Chavez VE. Immunocytochemical study of
amelogenin deposition during the early
odontogenesis of molars in alendronate-
treated newborn rats. J Histochem
Cytochem 2006;54:713-725.
22. Grier RL, Wise GE Inhibition of tooth erup-
tion in the rat by a bisphosphonate. J Dent
Res 1998;77:8-15.
23. Bradaschia-Correa V, Massa LF, Arana-
Chavez VE. Effects of alendronate on tooth
eruption and molar root formation in
young growing rats. Cell Tissue Res
2007;330:475-85.
24. Evans KD, Lau ST, Oberbauer AM, Martin
RB. Alendronate affects long bone length
and growth plate morphology in the oim
mouse model for Osteogenesis Imperfecta.
Bone 2003;32:268-74.
25. Larsson A. The effects of ethylene-1,1-dis-
phosphonate on the developing mandibu-
lar condyle – a light microscopic study.
Acta Odontol Scand 1977;35:217-23.
26. Larsson A, Larsson S-E. The effects of thy-
lene-1,1-disphosphonate on cellular trans-
formation and organic matrix of the epi-
physeal growth plate of the rat – a light
microscopic and ultrastructural study. Acta
Pathol Microbiol Scand A 1978;86:211-23.
27. Tabuchi M, Miyazawa K, Kimura M, Maeda
H, Kawai T, Kameyama Y, et al.
Enhancement of crude bone morphogenet-
ic protein-induced new bone formation
and normalization of endochondral ossifi-
cation by bisphosphonate treatment in
osteoprotegerin-deficient mice. Calcif
Tissue Int 2005;77:239-49.
28. Kimura M, Miyazawa K, Tabuchi M, Maeda
H, Kameyama Y, Goto S. Bisphosphonate
treatment increases the size of the
mandibular condyle and normalizes
growth of the mandibular ramus in osteo-
protegerin-deficient mice. Calcif Tissue
Int 2008;82:137-47.
29. Kim MS, Jung SY, Kang JH, Kim HJ, Ko
HM, Jung JY, et al. Effects of bisphospho-
nate on the endochondral bone formation
of the mandibular condyle. Anat Histol
Embryol 2009;38:321-6.
30. Massa LF, Arana-Chavez VE. Ultra -
structural preservation of rat embryonic
dental tissues after rapid fixation and
dehydratation under microwave irradia-
tion.  Eur J Oral Sci 2000;108:74-7.
31. Casa MA, Faltin RM, Faltin K, Arana-
Chavez VE. Root resorption on torqued
human premolars shown by tartrate-
resistant acid phosphatase histochemistry
and transmission electron microscopy.
Angle Orthod 2006;76:1015-21.
32. Lerner UH. Osteoclast formation and
resorption. Matrix Biol 2000;19:107-20.
Original Paper
